![{[Name]}](https://resource.bocsci.com/structure/1351556-81-4.gif?v=2025011501)
![{[Name]}](https://resource.bocsci.com/structure/2055022-35-8.gif?v=2025011501)
![{[Name]}](https://resource.bocsci.com/structure/944560-99-0.gif?v=2025011501)
![{[Name]}](https://resource.bocsci.com/structure/34450-18-5.gif?v=2025011501)
![{[Name]}](https://resource.bocsci.com/structure/82909-47-5.gif?v=2025011501)
![{[Name]}](https://resource.bocsci.com/structure/34993-56-1.gif?v=2025011501)
Inquiry Basket
Propargyl-PEG3-bromide | CAS 203740-63-0
| Catalog Number | R01-0182 |
| Category | Alkynes |
| Molecular Formula | C₉H₁₅BrO₃ |
| Molecular Weight | 251.12 |
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Product Introduction
Propargyl-PEG3-bromide is a polyethylene glycol (PEG)-based PROTAC linker. Propargyl-PEG3-bromide can be used in the synthesis of a series of PROTACs.
Chemical Information
Product Specification
Computed Properties
Patents
| Synonyms | Propargyl-PEG3-Br; 3-(2-(2-(2-Bromoethoxy)ethoxy)ethoxy)prop-1-yne; Alkyne-PEG3-Br |
| Purity | 98% |
| IUPAC Name | 3-[2-[2-(2-bromoethoxy)ethoxy]ethoxy]prop-1-yne |
| Canonical SMILES | C#CCOCCOCCOCCBr |
| InChI | InChI=1S/C9H15BrO3/c1-2-4-11-6-8-13-9-7-12-5-3-10/h1H,3-9H2 |
| InChIKey | UIGSOGCOFXYRNE-UHFFFAOYSA-N |
| Solubility | DMSO, DCM, DMF |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| XLogP3 | 0.7 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 9 |
| Exact Mass | 250.02046 g/mol |
| Monoisotopic Mass | 250.02046 g/mol |
| Topological Polar Surface Area | 27.7Ų |
| Heavy Atom Count | 13 |
| Formal Charge | 0 |
| Complexity | 141 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2022130046-A1 | N-1 branched imidazoquinolines, conjugates thereof, and methods | 2020-12-16 |
| WO-2021034729-A1 | N-aryl sulfonamide derivatives as vaccine adjuvant | 2019-08-16 |
| US-2022305121-A1 | N-aryl sulfonamide derivatives as vaccine adjuvant | 2019-08-16 |
| WO-2020010210-A1 | Mertk degraders and uses thereof | 2018-07-06 |
| US-2022356185-A1 | Mertk degraders and uses thereof | 2018-07-06 |
Recommended Services
Recommended Articles
- Hoechst Dyes: Definition, Structure, Mechanism and Applications
- Mastering the Spectrum: A Comprehensive Guide to Cy3 and Cy5 Dyes
- Fluorescent Probes: Definition, Structure, Types and Application
- Fluorescent Dyes: Definition, Mechanism, Types and Application
- Coumarin Dyes: Definition, Structure, Benefits, Synthesis and Uses
- BODIPY Dyes: Definition, Structure, Synthesis and Uses
- Cyanine Dyes: Definition, Structure, Types and Uses
- Fluorescein Dyes: Definition, Structure, Synthesis and Uses
- Rhodamine Dyes: Definition, Structure, Uses, Excitation and Emission
- Unlocking the Power of Fluorescence Imaging: A Comprehensive Guide
- Cell Imaging: Definitions, Systems, Protocols, Dyes, and Applications
- Lipid Staining: Definition, Principles, Methods, Dyes, and Uses
- Flow Cytometry: Definition, Principles, Protocols, Dyes, and Uses
- Nucleic Acid Staining: Definition, Principles, Dyes, Procedures, and Uses
- DNA Staining: Definition, Procedures, Benefits, Dyes and Uses
- Cell Staining: Definition, Principles, Protocols, Dyes, and Uses
- Ion Imaging: Definition, Principles, Benefits, Dyes, and Uses
- Fluorescent Labeling: Definition, Principles, Types and Applications
Recommended Products
Online Inquiry
